LRP1 Gene

LRP1 Gene

Introduction

[Lrp1](/genes/lrp1) Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene">
<div class="infobox-header">LRP1</div>
<div class="infobox-content">
<div class="infobox-row"><strong>Full Name:</strong> LDL Receptor Related Protein 1</div>
<div class="infobox-row"><strong>Chromosomal Location:</strong> 12q13.3</div>
<div class="infobox-row"><strong>NCBI Gene ID:</strong> 4035</div>
<div class="infobox-row"><strong>OMIM:</strong> 607737</div>
<div class="infobox-row"><strong>Ensembl ID:</strong> ENSG00000123329</div>
<div class="infobox-row"><strong>UniProt ID:</strong> Q07954</div>
<div class="infobox-row"><strong>Associated Diseases:</strong> Alzheimer's Disease, Cerebral Amyloid Angiopathy, Atherosclerosis</div>
</div>
</div>

Overview

[LRP1](/proteins/lrp1-protein) (LDL Receptor Related Protein 1) encodes a large endocytic receptor that belongs to the LDL receptor family. This multifunctional receptor plays critical roles in lipid metabolism, clearance of extracellular proteins, and synaptic function in the brain[@piehl2022].

Function

Receptors and Ligand Binding

LRP1 is a member of the LDL receptor family with diverse ligand binding capabilities:

LRP1 Gene

Introduction

[Lrp1](/genes/lrp1) Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene">
<div class="infobox-header">LRP1</div>
<div class="infobox-content">
<div class="infobox-row"><strong>Full Name:</strong> LDL Receptor Related Protein 1</div>
<div class="infobox-row"><strong>Chromosomal Location:</strong> 12q13.3</div>
<div class="infobox-row"><strong>NCBI Gene ID:</strong> 4035</div>
<div class="infobox-row"><strong>OMIM:</strong> 607737</div>
<div class="infobox-row"><strong>Ensembl ID:</strong> ENSG00000123329</div>
<div class="infobox-row"><strong>UniProt ID:</strong> Q07954</div>
<div class="infobox-row"><strong>Associated Diseases:</strong> Alzheimer's Disease, Cerebral Amyloid Angiopathy, Atherosclerosis</div>
</div>
</div>

Overview

[LRP1](/proteins/lrp1-protein) (LDL Receptor Related Protein 1) encodes a large endocytic receptor that belongs to the LDL receptor family. This multifunctional receptor plays critical roles in lipid metabolism, clearance of extracellular proteins, and synaptic function in the brain[@piehl2022].

Function

Receptors and Ligand Binding

LRP1 is a member of the LDL receptor family with diverse ligand binding capabilities:

• Lipoprotein receptors: Binds LDL, VLDL, and apolipoprotein E (ApoE)-containing lipoproteins
• Protein clearance: Mediates endocytosis of diverse ligands including [Aβ](/proteins/amyloid-beta), α2-macroglobulin, tPA, and matrix metalloproteinases
• Cell surface signaling: Triggers downstream signaling cascades upon ligand binding
• Synaptic function: Plays important roles in synaptic plasticity and neuronal survival[@herz2009]

Brain-Specific Functions

In the central nervous system, LRP1 serves critical functions:

• Blood-brain barrier (BBB) function: Expressed on brain endothelial cells and [pericytes](/cell-types/pericytes), regulates BBB integrity
• Aβ clearance: LRP1-mediated Aβ transport across the BBB is a major pathway for Aβ clearance from the brain
• Cholesterol homeostasis: Regulates neuronal cholesterol efflux and lipid transport
• Synaptic transmission: Modulates glutamate receptor trafficking and synaptic plasticity[@bu2009]

Disease Associations

Alzheimer's Disease

LRP1 is critically involved in Alzheimer's disease pathogenesis:

• Aβ clearance: LRP1 on brain endothelial cells mediates Aβ efflux from the brain to the bloodstream. Reduced LRP1 expression correlates with decreased Aβ clearance in AD brains[@shibata2000]
• ApoE interaction: LRP1 binds ApoE4 (the major genetic risk factor for AD) with lower affinity than ApoE3/ApoE2, potentially contributing to ApoE4-associated increased AD risk
• Genetic variants: LRP1 polymorphisms have been associated with altered AD risk and age of onset
• Therapeutic target: Enhancing LRP1-mediated Aβ clearance is a promising therapeutic strategy[@van2020]

Cerebral Amyloid Angiopathy (CAA)

LRP1 plays a role in vascular amyloid deposition:

• LRP1 mediates perivascular Aβ clearance along perivascular drainage pathways
• Dysfunction of LRP1 contributes to Aβ accumulation in cerebral blood vessels
• LRP1 expression is reduced in CAA-affected vessels[@wilhelmus2019]

Neuroinflammation

LRP1 modulates neuroinflammatory responses:

• Regulates microglial activation and cytokine production
• Controls matrix metalloproteinase (MMP) activity in the brain
• Modulates neuroimmune signaling pathways[@liu2010]

Expression

LRP1 exhibits tissue-specific and cell-type-specific expression:

• High expression: Brain, liver, lung, smooth muscle cells, fibroblasts
• Brain expression: [Neurons](/entities/neurons), [astrocytes](/entities/astrocytes), [microglia](/entities/microglia), brain endothelial cells, [pericytes](/cell-types/pericytes)
• Cellular localization: Cell surface membrane, early endosomes
• Regional expression: Highest expression in [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), and basal ganglia
• Allen Brain Atlas: Expression data available at [Human Brain Atlas](https://human.brain-map.org/microarray/search/show?search_term=LRP1)[@allen2020]

Therapeutic Implications

LRP1 is a promising therapeutic target for Alzheimer's disease:

• LRP1 agonists: Compounds that enhance LRP1 expression and function
• ApoE mimetics: Peptides that activate LRP1 signaling pathways
• Gene therapy: Approaches to increase LRP1 expression in the brain
• Combination therapy: LRP1 enhancement with other Aβ clearance mechanisms[@sagare2012]

LRP1 Signaling & Clearance Pathway

See Also

• [Blood-Brain Barrier](/entities/blood-brain-barrier)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Amyloid-beta](/proteins/amyloid-beta)
• [APOE Gene](/proteins/apoe)
• [Protein Aggregation](/mechanisms/protein-aggregation)

External Links

• [NCBI Gene: LRP1](https://www.ncbi.nlm.nih.gov/gene/4035)
• [UniProt: LRP1](https://www.uniprot.org/uniprot/Q07954)
• [OMIM: LRP1](https://www.omim.org/entry/607737)
• [Ensembl: LRP1](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000123329)
• [Allen Brain Atlas: LRP1](https://human.brain-map.org/microarray/search/show?search_term=LRP1)

Background

The study of Lrp1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Brain Atlas Resources

Allen Human Brain Atlas

• [Allen Human Brain Atlas - Gene Expression](https://human.brain-map.org/microarray/search/show?search_term=LRP1): Interactive gene expression data across the adult human brain

Allen Cell Type Atlas

• [Allen Cell Type Atlas](https://celltypes.brain-map.org/): Single-cell transcriptomics data for neuronal and glial cell types

BrainSpan Transcriptome Atlas

• [BrainSpan Atlas of the Developing Human Brain](https://www.brainspan.org/): Developmental gene expression data from prenatal to adult brain

Mouse Brain Atlas

• [Allen Mouse Brain Atlas](https://mouse.brain-map.org/): Comprehensive gene expression maps in the mouse brain

References

Related Hypotheses

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

• [Synthetic Biology BBB Endothelial Cell Reprogramming](/hypothesis/h-84808267) — <span style="color:#ffd54f;font-weight:600">0.56</span> · Target: TFR1, LRP1, CAV1, ABCB1
• [Circadian-Synchronized LRP1 Pathway Activation](/hypothesis/h-7e0b5ade) — <span style="color:#ffd54f;font-weight:600">0.52</span> · Target: LRP1, MTNR1A, MTNR1B
• [Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides](/hypothesis/h-b948c32c) — <span style="color:#ffd54f;font-weight:600">0.49</span> · Target: APOE, LRP1, LDLR
• [LRP1-Dependent Tau Uptake Disruption](/hypothesis/h-4dd0d19b) — <span style="color:#ffd54f;font-weight:600">0.48</span> · Target: LRP1

Pathway Diagram

The following diagram shows the key molecular relationships involving LRP1 Gene discovered through SciDEX knowledge graph analysis:

<!-- scidex-demo:links:start -->

SciDEX Links

Related Hypotheses

• [Synthetic Biology BBB Endothelial Cell Reprogramming](/hypothesis/h-84808267) — score 0.73; target TFR1, LRP1, CAV1, ABCB1; neurodegeneration.
• [Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides](/hypothesis/h-b948c32c) — score 0.72; target APOE, LRP1, LDLR; neurodegeneration.
• [Circadian-Synchronized LRP1 Pathway Activation](/hypothesis/h-7e0b5ade) — score 0.71; target LRP1, MTNR1A, MTNR1B; neurodegeneration.
• [LRP1-Dependent Tau Uptake Disruption](/hypothesis/h-4dd0d19b) — score 0.58; target LRP1; Alzheimer's Disease.

Related Analyses

• [Blood-brain barrier transport mechanisms for antibody therapeutics](/analyses/sda-2026-04-01-gap-008)
• [Tau propagation mechanisms and therapeutic interception points](/analyses/SDA-2026-04-02-gap-tau-prop-20260402003221)
• [Tau propagation mechanisms and therapeutic interception points](/analyses/SDA-2026-04-04-gap-tau-prop-20260402003221)

Associated Diseases

• Als — associated with

• ALS — associated with

• Alzheimer — associated with

• ALZHEIMER — associated with

• Alzheimer's disease — associated with

• Alzheimer's Disease — associated with

• Alzheimer'S Disease — associated with

• dementia — associated with

• Dementia — associated with

• DEMENTIA — associated with

• Late-Onset Alzheimer'S Disease — associated with

• Parkinson — associated with

• Parkinson's disease — associated with

• PARKINSON'S DISEASE — associated with